Banner Health-led and philanthropy-fueled study enables global research participation
Under the leadership of Nicholas Ashton, Ph.D., senior director of the Fluid Biomarker Program at Banner Sun Health Research Institute, an international collaborative effort has achieved remarkable results that exemplify the transformative power of sustained philanthropic investment in Alzheimer’s research.
The DROP-AD project, conducted across seven European medical centers, successfully tested 337 participants and proved that finger-prick blood collection can accurately measure key markers of Alzheimer’s pathology and brain damage. This breakthrough enables worldwide research participation by eliminating the logistical constraints that have historically limited biomarker studies to well-resourced medical facilities.
